Your weekly roundup of the latest news from Drug Topics®.
Pfizer-BioNTech hopes booster can be available for use this fall.
Domestic production to begin at Michigan-based pharmaceutical maker.
Consumers are purchasing dietary supplements that support or boost the immune system like never before.
The vaccine was previously authorized under an EUA for adults aged 18 and older.
Used to treat a variety of concerns and found in many medicine cabinets, new research indicates that nonsteroidal anti-inflammatory drugs may pose a risk to patients with type 2 diabetes.